Video: Profits Up 333%, Here Are 4 Strategies for MMIX's Aggressive Diaper-Tissue Business

Jakarta, CNBC Indonesia - The listed retailer in health and beauty distribution, PT Multi Medika Internasional Tbk (MMIX), successfully recorded a 333.3% profit growth throughout 2025, reaching Rp5.2 billion from Rp1.2 billion in 2024.

Founder and CEO of PT Multi Medika Internasional Tbk (MMIX), Mengky Mangarek, stated that MMIX’s positive performance, which successfully recorded profits and reversed losses, was supported by corporate strategies focused on developing ‘high-margin’ products and cost efficiency, such as baby diaper products that reached 40% of sales.

The over 300% profit growth, with revenue of Rp201.5 billion, was also supported by four strategies: technological product innovation, investment in expanding distribution channels, improvements in operational and logistical efficiency, and expansion of product types through alkaline water products and wet tissues.

What is the review of MMIX’s performance in 2025? How will MMIX’s business strategies face 2026? For more details, watch the dialogue between Serliana Salsabila and Founder and CEO of PT Multi Medika Internasional Tbk (MMIX), Mengky Mangarek, in Closing Bell, CNBC Indonesia (Tuesday, 14/04/2026).